CA1060888A - Cyclopentane derivatives - Google Patents

Cyclopentane derivatives

Info

Publication number
CA1060888A
CA1060888A CA206,171A CA206171A CA1060888A CA 1060888 A CA1060888 A CA 1060888A CA 206171 A CA206171 A CA 206171A CA 1060888 A CA1060888 A CA 1060888A
Authority
CA
Canada
Prior art keywords
alpha
hydroxy
group
formula
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA206,171A
Other languages
English (en)
French (fr)
Other versions
CA206171S (en
Inventor
George W. Holland
Jane L. Jernow
Perry Rosen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Application granted granted Critical
Publication of CA1060888A publication Critical patent/CA1060888A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0033—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing sulfur
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/005—Analogues or derivatives having the five membered ring replaced by other rings
    • C07C405/0058—Analogues or derivatives having the five membered ring replaced by other rings having the side-chains or their analogues or derivatives attached to a not condensed ring different from a five-membered ring
    • C07C405/0066—Analogues or derivatives having the five membered ring replaced by other rings having the side-chains or their analogues or derivatives attached to a not condensed ring different from a five-membered ring to a six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C53/00—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
    • C07C53/15—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen containing halogen
    • C07C53/19—Acids containing three or more carbon atoms
    • C07C53/21—Acids containing three or more carbon atoms containing fluorine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C53/00—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
    • C07C53/38—Acyl halides
    • C07C53/46—Acyl halides containing halogen outside the carbonyl halide group
    • C07C53/50—Acyl halides containing halogen outside the carbonyl halide group of acids containing three or more carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/141—Esters of phosphorous acids
    • C07F9/143—Esters of phosphorous acids with unsaturated acyclic alcohols
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/50—Organo-phosphines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/54—Quaternary phosphonium compounds
    • C07F9/5407—Acyclic saturated phosphonium compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
CA206,171A 1973-08-06 1974-08-02 Cyclopentane derivatives Expired CA1060888A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US38611773A 1973-08-06 1973-08-06
US05/480,458 US4052446A (en) 1973-08-06 1974-06-18 11,16-substituted prostaglandins
US06/026,125 US4226985A (en) 1973-08-06 1979-04-02 11-Substituted prostaglandins

Publications (1)

Publication Number Publication Date
CA1060888A true CA1060888A (en) 1979-08-21

Family

ID=27362698

Family Applications (1)

Application Number Title Priority Date Filing Date
CA206,171A Expired CA1060888A (en) 1973-08-06 1974-08-02 Cyclopentane derivatives

Country Status (10)

Country Link
US (2) US4052446A (enExample)
JP (1) JPS5817746B2 (enExample)
AT (1) AT347609B (enExample)
BE (1) BE818487A (enExample)
CA (1) CA1060888A (enExample)
CH (2) CH602627A5 (enExample)
DE (1) DE2437622C2 (enExample)
FR (3) FR2239998B1 (enExample)
GB (3) GB1485946A (enExample)
NL (1) NL181552C (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4218565A (en) * 1972-07-24 1980-08-19 American Cyanamid Company Novel 11-deoxy-11-substituted prostaglandins of the E and F series
US4187381A (en) * 1973-08-06 1980-02-05 Hoffmann-La Roche Inc. 16-Substituted prostaglandins
US4237276A (en) * 1974-06-18 1980-12-02 Hoffmann-La Roche Inc. Bicyclic lactone intermediates for 16-substituted prostaglandins
US3950363A (en) * 1975-03-10 1976-04-13 The Upjohn Company Prostaglandin cyclic ethers
US3996263A (en) * 1975-05-05 1976-12-07 Sankyo Company Limited 9-Oxo-11α-methyl-15Ε-hyroxyprost-13(trans)-enoic acid derivatives and process for the preparaion thereof
IN143632B (enExample) * 1975-07-30 1978-01-07 Ici Ltd
US4144251A (en) * 1976-03-02 1979-03-13 American Home Products Corporation 5-Unsaturated prostanoic acid derivatives
PT67818A (en) * 1977-03-28 1978-04-01 Union Carbide Corp Process for the synthesis of biocidal 2-aryl-1,3-cycloalkanedionas and their enol esters
US4204074A (en) * 1977-07-05 1980-05-20 Hoffmann-La Roche Inc. 16-Substituted prostaglandins
US4310543A (en) * 1980-10-09 1982-01-12 Hoffmann-La Roche Inc. Prostaglandin compositions
US4325970A (en) * 1980-10-09 1982-04-20 Hoffmann-La Roche Inc. 15-Acetyl-prostaglandins
US4568762A (en) * 1981-07-01 1986-02-04 Hoffmann-La Roche Inc. 4-Methyl-2-oxo-cyclopentylidene acetic acid and esters thereof
US4477684A (en) * 1982-06-23 1984-10-16 The Upjohn Company 11-Deoxy-11α-alkyl-PGE compounds from PGA compounds by lithium alkylation
US4739078A (en) * 1984-02-17 1988-04-19 The Upjohn Company Use of borohydride-salt lanthanide salt reagents for stereo selective reduction of C-15-keto prostaglandin precursors
US5057621A (en) * 1984-07-31 1991-10-15 Syntex (U.S.A.) Inc. 11-substituted-16-phenoxy and 16-substituted phenoxy-prostatrienoic acid derivatives
US4681962A (en) * 1985-06-24 1987-07-21 Hoffmann-La Roche Inc. Novel 7-fluoro-dihydro PGI compounds

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS503362B1 (enExample) * 1970-06-10 1975-02-04
US3903131A (en) * 1971-04-12 1975-09-02 Upjohn Co 16 and 16,16-dimethyl PGE{HD 2{B
US3849474A (en) * 1972-03-27 1974-11-19 Ayerst Mckenna & Harrison 11-deoxyprostaglandin derivatives and process therefor
US3816343A (en) * 1972-04-24 1974-06-11 Nl Industries Inc Kaolinite coated with synthesized layer-type silicate minerals
DE2317019A1 (de) * 1972-04-27 1973-11-08 Upjohn Co Neue 4,5-didehydro-prostaglandine
GB1396207A (en) * 1972-04-27 1975-06-04 Upjohn Co Prostaglandin intermediates and the preparation thereof
US3873607A (en) * 1972-07-24 1975-03-25 American Cyanamid Co 3-Oxa(and thia) 11-deoxy PGE
US4141914A (en) * 1972-07-24 1979-02-27 American Cyanamid Company Novel 11-deoxy-11-substituted prostaglandins of the E and F series
US3845042A (en) * 1972-08-21 1974-10-29 American Home Prod 11-substituted-prostaglandin derivatives
CH608012A5 (en) * 1972-10-25 1978-12-15 Hoffmann La Roche Process for the preparation of lactones
DE2317660A1 (de) * 1973-04-07 1974-10-24 Berstorff Gmbh Masch Hermann Fuenf-walzen-kalander

Also Published As

Publication number Publication date
AT347609B (de) 1979-01-10
NL7410487A (nl) 1975-02-10
FR2296631A1 (fr) 1976-07-30
GB1485291A (en) 1977-09-08
CH602627A5 (enExample) 1978-07-31
US4052446A (en) 1977-10-04
US4226985A (en) 1980-10-07
FR2296632A1 (fr) 1976-07-30
DE2437622C2 (de) 1984-05-30
ATA638274A (de) 1978-05-15
FR2296631B1 (enExample) 1979-09-28
FR2239998B1 (enExample) 1978-11-10
NL181552C (nl) 1987-09-16
BE818487A (fr) 1975-02-05
GB1485946A (en) 1977-09-14
FR2239998A1 (enExample) 1975-03-07
NL181552B (nl) 1987-04-16
FR2296632B1 (enExample) 1979-04-20
JPS5070341A (enExample) 1975-06-11
CH614193A5 (enExample) 1979-11-15
JPS5817746B2 (ja) 1983-04-09
DE2437622A1 (de) 1975-02-27
GB1485292A (en) 1977-09-08

Similar Documents

Publication Publication Date Title
CA1060888A (en) Cyclopentane derivatives
CA1079725A (en) Prostaglandin-acetylene analogues and process for their manufacture
US4024179A (en) Substituted ω-pentanorprostaglandins
Lee et al. Tandem reactions in 4-siloxy-1-benzopyrylium salts: introduction of substituents and cyclohexene and cyclopentane annulation in chromones
IE54097B1 (en) Azaprostacyclins, process for their manufacture and their pharmaceutical use
JPH0257548B2 (enExample)
CA1088931A (en) Preparation of 9-oxo tetrahydropyranyl substituted prostaglandin intermediates
DE2858694C2 (enExample)
FR2615516A1 (fr) Inhibiteurs de la hmg-coa reductase, contenant du phosphore, nouveaux intermediaires de ces inhibiteurs et procede pour leur preparation
SU679134A3 (ru) Способ получени 11-дезокси-16арилокси- -тетранорпростагландинов или их солей
DE2726857A1 (de) 9 alpha, 11 alpha-epoxymethano- oder 11 alpha, 9 alpha-epoxymethano-9, 11,15-trideoxy-prostaglandin f-analoga
EP0240107B1 (en) Thianaphthene derivatives, their production and use
HU193708B (en) Process for preparing the furyl derivatives of 16-substituted prostaglandines
CH617186A5 (enExample)
GB1569982A (en) Pyrrolidones and process for their manufacture
NL8200992A (nl) Fluorprostacyclinen, werkwijzen ter bereiding ervan alsmede farmaceutische preparaten die de fluorprostacyclinen bevatten.
CA1250835A (en) .alpha. CHAIN DIENIC PROSTANOIC ACID DERIVATIVES
CA1085859A (en) Pyrrolidones and process for their manufacture
US4404372A (en) 15-Substituted-ω-pentanorprostaglandin derivatives
US3836581A (en) 1-alkoximino-2-(omega-substituted-alkyl)-2-cyclopentenes
US4029693A (en) 2A,2B-Dihomo-11-deoxy-17(substituted phenyl)-18,19,20-trinor-PGE2 compounds and their corresponding esters
DE2606051A1 (de) 2,2-difluor-prostaglandin-e, -f tief alpha, -f tief beta, -a und -b-analoga und verfahren zu deren herstellung
Binghao et al. Mn (acac) 3 Promoted Radical Oxidative Coupling Reaction of Enol Esters with Phosphites to Synthesize β-Ketophosphonates
US4035360A (en) Magnesium salts of 2-descarboxy-2-(tetrazol-5-yl)-11-desoxy-15-substituted-omega-pentanoprostaglandins
IE43689B1 (en) 2-(w-haloalkenyl)-cyclopentane-1-heptanoic acids,methods for preparation thereof and their use